Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Clinical trial NCT00398905 · COMPLETED

Trial details

NCT number: NCT00398905
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2004-01-01
Enrollment: 726

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.